Legal & General Group
TIL icon

Legal & General Group’s Instil Bio TIL Stock Holding History

Legal & General Group’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-341
Closed -$4.51K – 3510
2023
Q1 		$4.51K Hold
341
– – ﹤0.01% 3313
2022
Q4 		$4.28K Hold
341
– – ﹤0.01% 3358
2022
Q3 		$33K Buy
341
+48
+16% +$5.49K ﹤0.01% 3074
2022
Q2 		$27K Buy
293
+6
+2% +$850 ﹤0.01% 3140
2022
Q1 		$61K Hold
287
– – ﹤0.01% 2966
2021
Q4 		$98K Buy
287
+168
+141% +$64.8K ﹤0.01% 2912
2021
Q3 		$43K Hold
119
– – ﹤0.01% 3020
2021
Q2 		$46K Buy
119
+94
+376% +$34.9K ﹤0.01% 2977
2021
Q1 		$13K Buy
+25
New +$12.8K ﹤0.01% 3312

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Legal & General Group's TIL Position: Q2 2023 in Review

Legal & General Group sold out of Instil Bio (TIL) in Q2 2023, closing a stake of 341 shares — an estimated $4.51K sold.

Legal & General Group first reported a position in TIL in Q1 2021 and held it in 9 quarters. The position peaked at $98K in Q4 2021. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2023.

  • Legal & General Group reported no remaining Instil Bio position as of Q2 2023 after selling out during the quarter.
  • Legal & General Group sold 341 Instil Bio shares in Q2 2023, an estimated $4.51K.
  • Legal & General Group first reported a position in Instil Bio in Q1 2021 and held it in 9 quarters.
  • Legal & General Group's Instil Bio position peaked at $98K in Q4 2021.
  • 62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2023.

Based on Legal & General Group's 13F filing for Q2 2023, filed 14 Aug 2023.